Benitec Biopharma Inc.
- BNTC
- NASDAQ
- Biotechnology
- RNAi Therapeutics
- Gene Therapy (AAV)
$8.11
Today −4.14%Quote Oct 16, 2026, 08:00 PM UTC
−28.61%over the last month
Max drawdown −28.6%From 1-month high −28.6%3 months −32.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$282.9M
Quote Oct 16
Next earnings
Nov 13
Expected, not confirmed
Analyst target
$21.00
+158.9% from here
Floor
$7.66
5.6% below price
Where the price sits
8 analysts
Analyst range, low to high
$17.00$25.00
- Price $8.11
- Resistance $8.26
- Consensus $21.00
The price is right under resistance. Analysts' average target sits about 159% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BNTCPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
24